BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18945881)

  • 1. Serological diagnosis of leprosy in patients in vietnam by enzyme-linked immunosorbent assay with Mycobacterium leprae-derived major membrane protein II.
    Kai M; Nguyen Phuc NH; Hoang Thi TH; Nguyen AH; Fukutomi Y; Maeda Y; Miyamoto Y; Mukai T; Fujiwara T; Nguyen TT; Makino M
    Clin Vaccine Immunol; 2008 Dec; 15(12):1755-9. PubMed ID: 18945881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of antibodies to both M. leprae PGL-I and MMP-II to recognize leprosy patients at an early stage of disease progression.
    Wang H; Liu W; Jin Y; Yu M; Jiang H; Tamura T; Maeda Y; Makino M
    Diagn Microbiol Infect Dis; 2015 Nov; 83(3):274-7. PubMed ID: 26320400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of serum antibodies to M. leprae major membrane protein-II in leprosy patients from Indonesia.
    Hatta M; Makino M; Ratnawati ; Mashudi ; Yadi ; Sabir M; Tandirogang N; Rusyati LM; Kai M; Fukutomi Y; Miyamoto Y; Mukai T; Maeda Y
    Lepr Rev; 2009 Dec; 80(4):402-9. PubMed ID: 20306638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological response in leprosy and tuberculosis patients to the 18-kDa antigen of Mycobacterium leprae and antigen 85B of Mycobacterium bovis BCG.
    Vikerfors T; Olcén P; Wiker H; Watson JD
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):571-80. PubMed ID: 8151188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
    Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients.
    Parkash O; Kumar A; Nigam A; Franken KL; Ottenhoff TH
    Scand J Immunol; 2006 Oct; 64(4):450-5. PubMed ID: 16970689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroreactivity to new Mycobacterium leprae protein antigens in different leprosy-endemic regions in Brazil.
    Hungria EM; Oliveira RM; Souza AL; Costa MB; Souza VN; Silva EA; Moreno FR; Nogueira ME; Costa MR; Silva SM; Bührer-Sékula S; Reed SG; Duthie MS; Stefani MM
    Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():104-11. PubMed ID: 23283461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-specific assessment of the immunological status of various groups in a leprosy endemic region.
    da Conceição Oliveira Coelho Fabri A; Carvalho AP; Araujo S; Goulart LR; de Mattos AM; Teixeira HC; Goulart IM; Duthie MS; Correa-Oliveira R; Lana FC
    BMC Infect Dis; 2015 May; 15():218. PubMed ID: 26021317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy.
    Spencer JS; Kim HJ; Wheat WH; Chatterjee D; Balagon MV; Cellona RV; Tan EV; Gelber R; Saunderson P; Duthie MS; Reece ST; Burman W; Belknap R; Mac Kenzie WR; Geluk A; Oskam L; Dockrell HM; Brennan PJ;
    Clin Vaccine Immunol; 2011 Feb; 18(2):260-7. PubMed ID: 21177913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological activity of natural disaccharide octyl bovine serum albumin (ND-O-BSA) in sera from patients with leprosy, tuberculosis, and normal controls.
    Wu QX; Ye GY; Li XY
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):50-5. PubMed ID: 3131466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of leprosy: serological aspects.
    Maeda Y
    Nihon Hansenbyo Gakkai Zasshi; 2006 Sep; 75(3):285-9. PubMed ID: 17037385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on a possibility of predicting early relapse in leprosy using a ND-O-BSA based ELISA.
    Wu Q; Yin Y; Zhang L; Chen X; Yu Y; Li Z; Yu H; Lu C; Feng S; Li X; Huo W; Ye G
    Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):1-8. PubMed ID: 12120035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serological response to the phenolic glycolipid of Mycobacterium leprae in Australian and Nepali leprosy patients.
    Britton WJ; Garsia RJ; Basten A
    Aust N Z J Med; 1987 Dec; 17(6):568-73. PubMed ID: 3328975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The result patterns of ML Flow and ELISA (PGL-I) serologic tests in leprosy-endemic and non-endemic areas.
    Silva RC; Lyon S; Araos R; Lyon AC; Grossi MA; Lyon SH; Penido RA; Bührer-Sékula S; Antunes CM
    Rev Soc Bras Med Trop; 2008; 41 Suppl 2():19-22. PubMed ID: 19618070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of major membrane protein-II as a tool for serodiagnosis of leprosy.
    Maeda Y; Mukai T; Kai M; Fukutomi Y; Nomaguchi H; Abe C; Kobayashi K; Kitada S; Maekura R; Yano I; Ishii N; Mori T; Makino M
    FEMS Microbiol Lett; 2007 Jul; 272(2):202-5. PubMed ID: 17521364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to a synthetic analog of phenolic glycolipid-I of Mycobacterium leprae in healthy household contacts of patients with leprosy.
    Menzel S; Harboe M; Bergsvik H; Brennan PJ
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):617-25. PubMed ID: 3323365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of IgM antibodies to PGL-I in the diagnosis of leprosy.
    Lefford MJ; Hunegnaw M; Siwik E
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):432-40. PubMed ID: 1890367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
    Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple dipstick assay for the detection of antibodies to phenolic glycolipid-I of Mycobacterium leprae.
    Bührer SS; Smits HL; Gussenhoven GC; van Ingen CW; Klatser PR
    Am J Trop Med Hyg; 1998 Feb; 58(2):133-6. PubMed ID: 9502593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.
    Meeker HC; Schuller-Levis G; Fusco F; Giardina-Becket MA; Sersen E; Levis WR
    Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):503-11. PubMed ID: 2205685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.